Şunu aradınız:: addition (Yunanca - İsveççe)

butter for the addition of tracers for use in accordance with article 3 (a) of regulation (ec) no 2571/97,
butter for the addition of tracers for use in accordance with article 3 (a) of regulation (ec) no 2571/97

butter for the concentration and the addition of tracers for use in accordance with article 3 (a) of regulation (ec) no 2571/97,
butter for the concentration and the addition of tracers for use in accordance with article 3 (a) of regulation (ec) no 2571/97

core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)